We develop, manufacture and commercialise the next generation of digital diagnostic products for clinicians and consumers.

Recent News

Featured Image

World TB Day 2020

  • Posted by Ellume
  • On March 25, 2020
#ItsTimeToEndTB: Diagnostics are critical in infectious disease control Written by Dr Sean Parsons, CEO Ellume. As the world rallies to curb the spread of COVID-19, this year’s World Tuberculosis Day serves as a stark reminder that the two major biological threats to humans are pandemic viruses (like COVID-19) and tuberculosis (TB) – especially multi-drug resistant […]
Read More
Featured Image

Ellume appoints Joanne Moss to its Board as Non-executive Director

  • Posted by Ellume
  • On November 12, 2019
Brisbane, Australia – 12 November 2019 Ellume Limited (Ellume) is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately. This appointment supports Ellume’s commitment to good governance and strengthens management resources in preparation for US commercialisation and potential upcoming […]
Read More
Featured Image

How Digital Diagnostics Are Changing Healthcare

  • Posted by Ellume
  • On October 1, 2019
The Importance of Accurate Tests to Good Medicine – Despite advances in healthcare over recent decades, infectious diseases remain burdensome illnesses. Influenza kills more people in America than car accidents, tuberculosis kills over 5,000 people every day around the world, and antimicrobial resistance is a growing threat.
Read More

SIGN UP FOR OUR NEWSLETTER